Literature DB >> 10417028

Treatment of ACE inhibitor-induced cough.

C A Luque1, M Vazquez Ortiz.   

Abstract

Angiotensin-converting enzyme (ACE) inhibitors are widely administered to treat numerous medical conditions. Although they are generally well tolerated, they are associated with a dry cough that can lead to discontinuation of treatment. Data concerning the frequency, onset, and clinical effects vary among the agents. When discontinuing the ACE inhibitor is not an ideal option, pharmacologic treatment of the cough may be considered, such as cromolyn, baclofen, theophylline, sulindac, and local anesthetics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417028     DOI: 10.1592/phco.19.10.804.31563

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  5 in total

Review 1.  [Good sense and nonsense of antitussive agents].

Authors:  A Gillissen; S Tasci; S Ewig; H Schäfer; S Zielen
Journal:  Internist (Berl)       Date:  2001-01       Impact factor: 0.743

2.  Difficulties in achieving arterial hypertension control.

Authors:  Genel Sur; Maria Sur; Liana Kudor-Szabadi; Lucia Sur
Journal:  Maedica (Buchar)       Date:  2011-04

3.  Effectiveness, safety and cost of drug substitution in hypertension.

Authors:  Atholl Johnston; Panagiotis Stafylas; George S Stergiou
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

4.  Zofenopril and incidence of cough: a review of published and unpublished data.

Authors:  Stefano Omboni; Claudio Borghi
Journal:  Ther Clin Risk Manag       Date:  2011-11-29       Impact factor: 2.423

Review 5.  Angiotensin-converting enzyme inhibitors side effects--physiologic and non-physiologic considerations.

Authors:  Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-07       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.